BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhattacharya S. Genotoxicity and in vitro investigation of Gefitinib-loaded polycaprolactone fabricated nanoparticles for anticancer activity against NCI-H460 cell lines. Journal of Experimental Nanoscience 2022;17:214-46. [DOI: 10.1080/17458080.2022.2060501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sherif AY, Harisa GI, Shahba AA, Alanazi FK, Qamar W. Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer. Molecules 2023;28. [PMID: 36615641 DOI: 10.3390/molecules28010448] [Reference Citation Analysis]
2 Li J, Zhu L, Kwok HF. Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment. Drug Resist Updat 2023;66:100904. [PMID: 36462375 DOI: 10.1016/j.drup.2022.100904] [Reference Citation Analysis]
3 Li N, Li G, Li R, Karmakar B, El-kott AF, Bani-fwaz MZ, Negm S, Morsy K. Synthesis of Au NPs/Quince nanoparticles mediated by Quince extract for the treatment of human cervical cancer: Introducing a novel chemotherapeutic supplement. mat express 2022;12:1465-1473. [DOI: 10.1166/mex.2022.2300] [Reference Citation Analysis]
4 Bhattacharya S, Singh D, Aich J, Ajazuddin, Shete MB. Development and characterization of Hyaluronic acid surface scaffolds Encorafenib loaded polymeric Nanoparticles for colorectal cancer targeting. Materials Today Communications 2022. [DOI: 10.1016/j.mtcomm.2022.103757] [Reference Citation Analysis]